Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco.

[1]  D. Glidden,et al.  Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP). , 2020, AIDS.

[2]  P. Volberding,et al.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. , 2020, JAMA.

[3]  S. Buchbinder,et al.  Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Buchbinder,et al.  Getting to Zero San Francisco: A Collective Impact Approach. , 2019, Journal of acquired immune deficiency syndromes.

[5]  D. Havlir,et al.  RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. , 2019, AIDS.

[6]  C. del Rio,et al.  Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States , 2018, Open forum infectious diseases.

[7]  T. Klimkait,et al.  Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial , 2018, JAMA.

[8]  L. Myers,et al.  Linkage and Antiretroviral Therapy Within 72 Hours at a Federally Qualified Health Center in New Orleans , 2018, AIDS patient care and STDs.

[9]  J. Pape,et al.  Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial , 2017, PLoS medicine.

[10]  H. Hatano,et al.  The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting , 2017, Journal of acquired immune deficiency syndromes.